Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Mathew

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Cytogenetics and Cell Genetics|January 1, 1987
Exclusion of linkage of loci on chromosome 19 with multiple endocrine neoplasia, type 2C Carter, D F Easton, C G Mathew, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1996
[Molecular analysis of the estrogen receptor (ER) gene in association with ER negativity in breast cancer]H Iwase, S Kobayashi, H Iwata, et al.
Nature|August 6, 1987
Deletion of genes on chromosome 1 in endocrine neoplasiaC G Mathew, B A Smith, K Thorpe, et al.
Collagen and Related Research|April 1, 1987
The gene coding for tropoelastin is represented as a single copy sequence in the haploid sheep genomeL Olliver, P A Luvalle, J M Davidson, et al.
Genes, Chromosomes & Cancer|June 1, 1992
Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosisW Xu, L M Mulligan, M A Ponder, et al.
Journal of Medical Genetics|September 1, 1987
Linkage analysis of British and Indian families with Von Recklinghausen neurofibromatosisC G Mathew, K Thorpe, D F Easton, et al.
Cytogenetic and Genome Research|May 27, 2004
Quantitative PCR analysis reveals a high incidence of large intragenic deletions in the FANCA gene in Spanish Fanconi anemia patientsE Callén, M D Tischkowitz, A Creus, et al.
Cancer Medicine|March 5, 2025
Breast Cancer Genetic Services in a South African Setting: Proband Testing, Cascading and Clinical ManagementT S Osler, M Schoeman, J Edge, et al.
Gut|June 2, 2005
Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's diseaseD A van Heel, S Ghosh, K A Hunt, et al.
Journal of Medical Genetics|June 3, 1999
Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancerS V Hodgson, E Heap, J Cameron, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Cytogenetics and Cell Genetics|January 1, 1987
Exclusion of linkage of loci on chromosome 19 with multiple endocrine neoplasia, type 2C Carter, D F Easton, C G Mathew, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1996
[Molecular analysis of the estrogen receptor (ER) gene in association with ER negativity in breast cancer]H Iwase, S Kobayashi, H Iwata, et al.
Nature|August 6, 1987
Deletion of genes on chromosome 1 in endocrine neoplasiaC G Mathew, B A Smith, K Thorpe, et al.
Collagen and Related Research|April 1, 1987
The gene coding for tropoelastin is represented as a single copy sequence in the haploid sheep genomeL Olliver, P A Luvalle, J M Davidson, et al.
Genes, Chromosomes & Cancer|June 1, 1992
Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosisW Xu, L M Mulligan, M A Ponder, et al.
Journal of Medical Genetics|September 1, 1987
Linkage analysis of British and Indian families with Von Recklinghausen neurofibromatosisC G Mathew, K Thorpe, D F Easton, et al.
Cytogenetic and Genome Research|May 27, 2004
Quantitative PCR analysis reveals a high incidence of large intragenic deletions in the FANCA gene in Spanish Fanconi anemia patientsE Callén, M D Tischkowitz, A Creus, et al.
Cancer Medicine|March 5, 2025
Breast Cancer Genetic Services in a South African Setting: Proband Testing, Cascading and Clinical ManagementT S Osler, M Schoeman, J Edge, et al.
Gut|June 2, 2005
Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's diseaseD A van Heel, S Ghosh, K A Hunt, et al.
Journal of Medical Genetics|June 3, 1999
Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancerS V Hodgson, E Heap, J Cameron, et al.
Pageof 13